Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cti Biopharm Corp (NQ: CTIC ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jun 23, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cti Biopharm Corp < Previous 1 2 3 4 Next > Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival September 18, 2023 Both companies now sell treatments for myelofibrosis, a rare bone marrow cancer. Via Investor's Business Daily CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC June 06, 2023 From Kahn Swick & Foti, LLC Via Business Wire CTI BioPharma Corp. (NASDAQ: CTIC) Climbs to New 52-Week High May 23, 2023 Via Investor Brand Network Top 5 Health Care Stocks That Should Keep You Up At Night May 23, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023 May 16, 2023 Via Benzinga The Latest Analyst Ratings for CTI BioPharma May 15, 2023 Via Benzinga Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet May 11, 2023 Investors are on the hunt for undervalued, underfollowed and emerging stocks and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023 May 11, 2023 Via Benzinga CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC May 10, 2023 From Kahn Swick & Foti, LLC Via Business Wire Dow Falls 90 Points; Mesa Air Group Shares Plummet May 10, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1% points on Wednesday. The Dow traded down 0.27% to 33,471.60 while the NASDAQ rose 1.01% to 12,302.61. The... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 10, 2023 Via Benzinga Nasdaq, S&P 500 Higher As Bond Yields Retreat May 10, 2023 Investor sentiment is boosted today by a better-than-expected consumer price index (CPI) reading for April. Via Talk Markets BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Syneos Health, Inc. (Nasdaq – SYNH), Franchise Group, Inc. (Nasdaq – FRG), CTI BioPharma Corp. (Nasdaq – CTIC), Ruth’s Inc. (Nasdaq – RUTH) May 10, 2023 From Brodsky & Smith LLC Via GlobeNewswire Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 10, 2023 Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. Via Benzinga Crude Oil Down 1%; Microvast Holdings Shares Spike Higher May 10, 2023 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded down 0.28% to 33,469.12 while the NASDAQ rose 0.75% to 12,270.95. The S&P... Via Benzinga Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday May 10, 2023 U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga CTI BioPharma Corp. (NASDAQ: CTIC) Near Top of Volume Charts in Wednesday Trading May 10, 2023 Via Investor Brand Network Why Shares of CTI BioPharma Are Soaring Wednesday May 10, 2023 A buyout offer from Swedish Orphan Biovitrum drove up the stock's price. Via The Motley Fool Nasdaq Surges Over 1%; US Inflation Falls In April May 10, 2023 U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Wednesday. Via Benzinga SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today May 10, 2023 Syneos Health (SYNH) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal with a group of investors. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 10, 2023 Via Benzinga Why Is SeaStar Medical (ICU) Stock Down 32% Today? May 10, 2023 SeaStar Medical (ICU) stock is falling on Wednesday after the medical technology company got a rejection letter from the FDA. Via InvestorPlace Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket May 10, 2023 Gainers Unique Fabricating, Inc. (NYSE: UFAB) gained 88.8% to $0.34 in pre-market trading after gaining around 4% on Tuesday. Via Benzinga CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders May 10, 2023 From Halper Sadeh LLC Via Business Wire Why Is Babylon (BBLN) Stock Down 57% Today? May 10, 2023 Babylon (BBLN) stock is falling on Wednesday after the health services company revealed earnings and a plan to go private. Via InvestorPlace Why Is CTI BioPharma (CTIC) Stock Up 85% Today? May 10, 2023 CTI BioPharma (CTIC) stock is taking off on Wednesday after the company announced a major $1.7 billion acquisition deal with Sobi. Via InvestorPlace European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B May 10, 2023 Swedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday May 10, 2023 It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! Via InvestorPlace What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks April 21, 2023 Incyte Corporation (NASDAQ: INCY) will report Q1 FY23 results on May 2. Investor focus remains on the Opzelura launch, which has faced some hiccups over the first 18 months of launch and began to gain... Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session April 12, 2023 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.